Spring direct naar de hoofdnavigatie of de inhoud

Blijke Kroezen

Patent attorney

“Innovation is the process of turning ideas into manufacturable and marketable form. (Watts Humprey)”
Home / Experts / Blijke Kroezen

Blijke Kroezen

Blijke Kroezen

  • Life Sciences
  • Trainee Patent Attorney

Blijke Kroezen studied chemistry at the university of Groningen. For her Master’s research she worked on the development of novel medicines for malaria and tuberculosis. She was primarily responsible for the organic synthesis of the molecules, but was also involved in the design of the scaffolds using molecular modelling tools and the development of new in vitro assays to determine the affinity of the molecules.

More information about Blijke

She particularly enjoyed the multidisciplinary character of the research project and therefore decided in 2013 to pursue a PhD at the Faculty of Pharmaceutical Sciences at the University of Basel. During her PhD she started a new research project on the development of novel medicines for asthma. For four years, she specialized primarily in the design and synthesis of carbohydrates and carbohydrate-mimetics. In 2017, she obtained her PhD summa cum laude and in the same year she started as a trainee patent attorney at V.O.

Education

  • MSc in Chemistry, University of Groningen (2012)
  • PhD in Pharmaceutical Sciences, University of Basel (2017)

Publications

  • Masini, T., Pilger, J., Kroezen, B. S., Illarionov, B., Lottmann, P., Fischer, M., Griesinger C. and Hirsch, A. K. H., Chemical Science, 2014, 5, 3543-3551.
  • Masini, T., Kroezen, B.S., Hirsch, A.K.H., Drug Discovery Today, 2013, 18, 1256-1262.

Languages

  • Dutch
  • English
  • German

 

Also see these experts

Tamara Elmore

  • European Patent Attorney
  • Dutch Patent Attorney
  • United States Patent Agent
  • Senior Associate

Mark Einerhand

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner
More experts

News

The consequences of the Nagoya Protocol

  The Nagoya Protocol is highly relevant for the Dutch seed culture sector. But the content of the protocol is far from easy to understand. IP Leads summarises the main provisions for you and the most important consequences.Continue reading

No happy ending for a pharmaceutical company in a case involving a Native American tribe

In the case known as Mohawk tribe versus Mylan, the US Federal Circuit Court of Appeals ruled that patent holders cannot shield themselves from an “inter partes review” of a patent by assigning that patent to a Native American tribe. Ironically enough, this is due to the fact that the decision handed down by the […]Continue reading

Does the new law for the protection of trade secrets offer sufficient protection?

On 9 June, the new law for the protection of trade secrets came into force (based on European Directive 2016/943/EU). On the basis of the law, it is possible to take action against the illegal acquisition, use and disclosure of trade secrets. If a trade secret is misused, the holder can bring various actions based […]Continue reading

Events

European Biotech and Pharma Partnering Conference 2018

Osaka, Japan,Congres Convention Centre Second Basement, North Building, Grand Front Osaka

The European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for potential partners in the EU and Japan to ensure sustainable business development and growth. More about this event

BIO JAPAN 2018 – Flemish Life Sciences & Biotech Week

Pacifico Yokohama, 1 Chome-1 Minatomirai, Nishi Ward, Yokohama, Kanagawa, Japan

Asia's Premier Partnering Event for the Global Biotechnology Industry BioJapan has played an important role in facilitating interaction between Japanese and global companies/organizations and stimulating new business opportunities for almost two decades. More about this event

The London IP Summit 2018

Four Seasons Hotel London at Park Lane, Hamilton Place, Park Lane, London, Verenigd Koninkrijk

The London IP Summit is an industry leading event dedicated to bringing together IP owners, experts and investors to address key challenges and operational issues faced by companies and IP professionals today. More about this event